Grand challenges in dermatologic drug discovery: four priorities to transform skin disease treatment

Frontiers in Drug Discovery · Published 2026-01-05 · DOI 10.3389/fddsv.2025.1752852

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.3389/fddsv.2025.1752852

Abstract

DOAJ holds no abstract for this record.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Standardization of canine infections for the development of antileishmanial drugs · Frontiers in Drug Discovery · 2026 · Same journal
• Toward explainable and adaptive artificial intelligence systems for antimicrobial peptide discovery under resistance pressure · Frontiers in Drug Discovery · 2026 · Same journal
• Engineering hope: biomaterial strategies against glioblastoma · Frontiers in Drug Discovery · 2026 · Same journal
• Decoding lung complexity: single-cell sequencing in lung diseases, regeneration, and drug discovery · Frontiers in Drug Discovery · 2024 · Same journal
• Validation of an MPS-based intestinal cell culture model for the evaluation of drug-induced toxicity · Frontiers in Drug Discovery · 2025 · Same journal
• Redefining the geography of pharmaceutical innovation: Kelly Chibale as a harbinger for integrated drug discovery in Africa · Frontiers in Drug Discovery · 2026 · Same journal
• Mapping the otoactive landscape: an LLM-aided extraction of compounds and their targets · Frontiers in Drug Discovery · 2026 · Same journal
• AI-driven innovation in antibody-drug conjugate design · Frontiers in Drug Discovery · 2025 · Same journal
• Virtual screening and molecular dynamics simulations of cannabinoid receptor 2 agonists as drug candidates for osteoarthritis therapy · Frontiers in Drug Discovery · 2026 · Same journal
• Bioinformatics-driven identification and prioritization of PTSD targets based on published multi-omic data · Frontiers in Drug Discovery · 2025 · Same journal